We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Yutaka Seino MD, PhD

Yutaka Seino MD, PhD

President, Kansai Electric Power Hospital, Osaka, Japan; Chairman, The Asian Association for the Study of Diabetes; Chairman, The Japan Association for Diabetes Education and Care.


Consulting and/or speaker fees from Eli Lilly and Company, Sanofi, Novo Nordisk, Glaxo-Smith-Kline, Taisho pharmaceutical, Astellas Pharma, BD, Boehringer Ingelheim, Johnson & Johnson, Takeda pharmaceuticals, Kyowa Kirin, MSD, and Ono pharmaceutical.

Recent Contributions to PracticeUpdate:

  1. Ethnic-Specific Obesity Cutoffs for Diabetes Risk